Sponsored Helpline
Researchers found that an artificial intelligence screening tool identified at-risk patients and prompted referrals to addiction specialists as reliably as doctors did on their own, and the patients it flagged were far less likely to land back in the hospital.
The findings come from a clinical trial published in Nature Medicine and supported by the National Institutes of Health. The research team at the University of Wisconsin School of Medicine and Public Health tested the tool across 51,760 adult hospitalizations in Madison, Wisconsin.
What the Study Found
The AI system read the notes and medical history already sitting in a patient’s electronic health record, looked for patterns linked to opioid use disorder, and alerted providers to consider an addiction-medicine consultation and to watch for withdrawal.
Patients screened with the AI tool had 47% lower odds of being readmitted within 30 days compared with those who received a standard provider-initiated referral.
About 8% of patients in the AI group were readmitted, against roughly 14% in the traditional group. The reduction held after researchers accounted for age, sex, race and ethnicity, insurance status, and other health conditions.
Over the eight-month period the tool was running, the researchers estimated about $108,800 in healthcare savings, even after the cost of maintaining the software. The average 30-day readmission is currently estimated at $16,300.
Why This Matters for Addiction Treatment
Hospital stays are a common moment when opioid use disorder goes unaddressed. Screening is inconsistent, and patients often leave before an addiction specialist ever sees them, which researchers link to a sharply higher overdose risk after discharge.
Catching the condition earlier opens the door to medication-assisted treatment (MAT), which pairs FDA-approved medications such as buprenorphine with counseling and is a standard, evidence-based approach to opioid use disorder. A referral made in the hospital can become the first step into ongoing care at a rehab or outpatient program.
“Addiction care remains heavily underprioritized and can be easily overlooked, especially in overwhelmed hospital settings,” said Nora D. Volkow, M.D., director of the National Institute on Drug Abuse, in the NIH announcement.
Study lead author Majid Afshar, M.D., of the University of Wisconsin-Madison, called it one of the first AI screening tools embedded directly into hospital addiction-medicine workflows.
The authors noted real limits. Providers can experience alert fatigue, the tool needs testing in other health systems, and the shifting nature of the opioid crisis may have affected results. More research is planned.
What This Means for Treatment Seekers
If you or a loved one is hospitalized and struggling with opioids, you can ask directly whether an addiction-medicine consultation is available before discharge.
The period right after a hospital stay carries a high overdose risk, so lining up treatment early matters. Knowing your insurance coverage for rehab and what level of care fits can make that handoff smoother.
Finding the Right Rehab
If a hospital visit has made the need for help clear, the next step is comparing treatment options that fit your situation: medication-assisted treatment for opioid use disorder, inpatient or outpatient care, and programs that coordinate with hospital discharge.
Verifying a facility’s credentials and treatment approach helps you choose with confidence. Rehab.com’s directory includes verified rehab centers nationwide, where you can compare programs and connect with a treatment advisor.
